UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form N-8F

Application for Deregistration of Certain Registered Investment Companies.

I.	General Identifying Information

1.	Reason fund is applying to deregister (check only one; for descriptions, see Instruction 1 above):

o	Merger

x	Liquidation

o	Abandonment of Registration
	(Note: Abandonments of Registration answer only questions 1 through 15, 24 and 25 of this form and complete verification at the end of the form.)

o	Election of status as a Business Development Company
	(Note: Business Development Companies answer only questions 1 through 10 of this form and complete verification at the end of the form.)

Name of fund:

UBS Health Sciences Fund, L.L.C.

Securities and Exchange Commission File No.:

811-09985

4.	Is this an initial Form N-8F or an amendment to a previously filed Form N-8F?

Initial Application

Amendment

5.	Address of Principal Executive Office (include No. & Street, City, State, Zip Code):

c/o UBS Financial Services Inc., 51 West 52nd Street, New York, New York 10019

6.	Name, address and telephone number of individual the Commission staff should contact with any questions regarding this form:

Steven S. Drachman, UBS Financial Services Inc., 51 West 52nd Street, New York, New York 10019, Telephone number (212) 882-5819

7.	Name, address and telephone number of individual or entity responsible for maintenance and preservation of fund records in accordance with rules 31a-1 and 31a-2 under the Act [17 CFR 270.31a-1, .31a-2]:

PFPC Inc., 103 Bellevue Parkway, Wilmington, Delaware 19809, Attn: Dan Lennick, Telephone Number: 302-791-3108

NOTE: Once deregistered, a fund is still required to maintain and preserve the records described in rules 3la-1 and 3la-2 for the periods specified in those rules.

8.	Classification of fund (check only one):

x	Management company;

o	Unit investment trust; or

o	Face-amount certificate company.

9.	Subclassification if the fund is a management company (check only one):

Open-end

Closed-end

10.	State law under which the fund was organized or formed (e.g., Delaware, Massachusetts):

Delaware

11.	Provide the name and address of each investment adviser of the fund (including sub-advisers) during the last five years, even if the fund’s contracts with those advisers have been terminated:

UBS Fund Advisor, L.L.C., 51 West 52nd Street, New York, New York 10019

12.	Provide the name and address of each principal underwriter of the fund during the last five years, even if the fund’s contracts with those underwriters have been terminated:

UBS Financial Services Inc., 51 West 52nd Street, New York, New York 10019

13.	If the fund is a unit investment trust (“UIT”) provide:

(a)

Depositor’s name(s) and address(es):

(b)

Trustee’s name(s) and address(es):

14.	Is there a UIT registered under the Act that served as a vehicle for investment in the fund (e.g., an insurance company separate account)?

Yes

If Yes, for each UIT state:

Name(s):

File No.: 811-_________

Business Address:

15.

(a)

Did the fund obtain approval from the board of directors concerning the decision to engage in a Merger, Liquidation or Abandonment of Registration?

Yes

If Yes, state the date on which the board vote took place: July 20, 2007

If No, explain:

(b)

Did the fund obtain approval from the shareholders concerning the decision to engage in a Merger, Liquidation or Abandonment of Registration?

Yes

If Yes, state the date on which the shareholder vote took place:

		If No, explain: The terms of the fund’s limited liability company agreement permit its dissolution upon the determination by the fund’s investment adviser to do so.

II.

Distributions to Shareholders

16.	Has the fund distributed any assets to its shareholders in connection with the Merger or Liquidation?

Yes

(a)

If Yes, list the dates on which the fund made those distributions:

10-26-2007

01-18-2008

06-19-2008

(b)

Were the distributions made on the basis of net assets?

Yes

(c)

Were the distributions made pro rata based on share ownership?

Yes

(d)

If No to (b) or (c) above, describe the method of distributions to shareholders. For Mergers, provide the exchange ratio(s) used and explain how it was calculated:

(e)

Liquidations only:

Were any distributions to shareholders made in kind?

Yes

If Yes, indicate the percentage of fund shares owned by affiliates, or any other affiliation of shareholders:

17.	Closed-end funds only:

Has the fund issued senior securities?

Yes

If Yes, describe the method of calculating payments to senior securityholders and distributions to other shareholders:

18.	Has the fund distributed *all* of its assets to the fund’s shareholders?

Yes

If No,

(a)

How many shareholders does the fund have as of the date this form is filed?

(b)

Describe the relationship of each remaining shareholder to the fund:

19.	Are there any shareholders who have not yet received distributions in complete liquidation of their interests?

Yes

If Yes, describe briefly the plans (if any) for distributing to, or preserving the interests of, those shareholders:

III.

Assets and Liabilities

20.	Does the fund have any assets as of the date this form is filed?

(See question 18 above)

Yes

If Yes,

(a)

Describe the type and amount of each asset retained by the fund as of the date this form is filed:

(b)

Why has the fund retained the remaining assets?

(c)

Will the remaining assets be invested in securities?

Yes

21.	Does the fund have any outstanding debts (other than face-amount certificates if the fund is a face-amount certificate company) or any other liabilities?

Yes

If Yes,

(a)

Describe the type and amount of each debt or other liability:

(b)

How does the fund intend to pay these outstanding debts or other liabilities?

IV.

Information About Event(s) Leading to Request For Deregistration

22.

(a)

List the expenses incurred in connection with the Merger or Liquidation:

(i)	Legal expenses: $10,000

(ii)	Accounting expenses: 0

(iii)	Other expenses (list and identify separately):

	Custody fees:	0
	Printing:	$1,045
	Administration	0

(iv)	Total expenses (sum of lines (i)-(iii) above): $11,045

(b)

How were those expenses allocated? The expenses were allocated based on Members Capital percentage

(c)

Who paid those expenses? All expenses incurred in connection with the liquidation of the Fund were paid by the Fund

(d)

How did the fund pay for unamortized expenses (if any)? N/A

23.	Has the fund previously filed an application for an order of the Commission regarding the Merger or Liquidation?

Yes

If Yes, cite the release numbers of the Commission’s notice and order or, if no notice or order has been issued, the file number and date the application was filed:

V.	Conclusion of Fund Business

24.	Is the fund a party to any litigation or administrative proceeding?

Yes

If Yes, describe the nature of any litigation or proceeding and the position taken by the fund in that litigation:

25.	Is the fund now engaged, or intending to engage, in any business activities other than those necessary for winding up its affairs?

Yes

If Yes, describe the nature and extent of those activities:

VI.

Mergers Only

26.

(a)

State the name of the fund surviving the Merger:

(b)

State the Investment Company Act file number of the fund surviving the Merger:

(c)

If the merger or reorganization agreement has been filed with the Commission, state the file number(s), form type used and date the agreement was filed:

(d)

If the merger or reorganization agreement has not been filed with the Commission, provide a copy of the agreement as an exhibit to this form.

VERIFICATION

The undersigned states that (i) he has executed this Form N-8F application for an order under section 8(f) of the Investment Company Act of 1940 on behalf of UBS Health Sciences Fund, L.L.C., (ii) he is an Authorized Signatory on behalf of UBS Fund Advisor, L.L.C., the investment adviser of UBS Health Sciences Fund, L.L.C., and (iii) all actions by shareholders, directors, and any other body necessary to authorize the undersigned to execute and file this Form N-8F application have been taken. The undersigned also states that the facts set forth in this Form N-8F application are true to the best of his knowledge, information and belief.

/s/ Robert F. Aufenanger

Robert F. Aufenanger